Cetuximab as salvage monotherapy in chemotherapy-refractory metastatic colorectal cancer: A single-center report

In July 2008, cetuximab, a monoclonal antibody against epidermal growth factor receptor (EGFR), was approved in Japan for clinical use against chemotherapy-refractory metastatic colorectal cancer (mCRC). At Shiga University of Medical Science, between December 2007 and April 2012, a total of 24 EGFR...

Descripción completa

Detalles Bibliográficos
Autores principales: MEKATA, EIJI, ENDO, YOSHIHIRO, SONODA, HIROMICHI, SHIMIZU, TOMOHARU, KAWAI, YUKI, UMEDA, TOMOKO, SHIOMI, HISANORI, NAKA, SHIGEYUKI, KUBOTA, YOSHIHIRO, MURATA, SATOSHI, YAMAMOTO, HIROSHI, ABE, HAJIME, TANI, TOHRU
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796414/
https://www.ncbi.nlm.nih.gov/pubmed/24137455
http://dx.doi.org/10.3892/ol.2013.1477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796414/
https://www.ncbi.nlm.nih.gov/pubmed/24137455
http://dx.doi.org/10.3892/ol.2013.1477

Ejemplares similares